Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Avelumab (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary) ; Mitomycin (Primary)
- Indications Bladder cancer; Carcinoma; Ureteral neoplasms; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- 27 Nov 2018 Status changed from suspended to recruiting.
- 02 Oct 2018 Status changed from not yet recruiting to suspended.
- 17 Sep 2018 Planned initiation date changed from 31 Aug 2018 to 31 Oct 2018.